Covid-19 News and Discussions

atlantic.ctvnews.ca

COVID-19 rapid tests will stop being distributed once supplies run out: N.B. government

COVID-19 rapid tests in New Brunswick will stop being distributed through community-based distribution sites when the current supply runs out, which the province says will likely be by the end of next month.
atlantic.ctvnews.ca atlantic.ctvnews.ca

COVID-19 rapid tests will stop being distributed once supplies run out: N.B. government​

The contents of a COVID-19 antigen rapid test kit are picture in Calgary, Alta., Tuesday, Jan. 4, 2022. THE CANADIAN PRESS/Jeff McIntosh
The contents of a COVID-19 antigen rapid test kit are picture in Calgary, Alta., Tuesday, Jan. 4, 2022. THE CANADIAN PRESS/Jeff McIntosh

Leigha Kaiser
CTVNewsAtlantic.ca writer
Contact
Published May 16, 2024 1:53 p.m. EDT
Share
  • Link
  • X
  • Reddit
  • LinkedIn
  • Email
COVID-19 rapid tests in New Brunswick will stop being distributed through community-based distribution sites when the current supply runs out, which the province says will likely be by the end of next month.
A news release(opens in a new tab) from the New Brunswick government Thursday says, aside from a few specific groups, testing hasn't been recommended for the general public since March 2023. Separate testing guidelines remain in place for certain settings, such as special care homes.

“However, our guidance has changed throughout the pandemic as the virus has evolved," said Dr. Yves Léger, the province’s acting chief medical officer of health. "Testing will still be recommended for certain groups but, for the general public, the focus is on staying home when you are ill. That remains the most important measure to take.”

RELATED STORIES​

Lab-based PCR tests will remain available for anyone with a referral from a doctor or nurse practitioner, including those eligible for Paxlovid treatment.
Léger said PCR tests is still the preferred option for those eligible for testing, as it provides for reliable results and can test for other infections, such as influenza and respiratory syncytial virus, commonly known as RSV.
The government's release says the decision to stop handing out rapid rests follows the federal government's decision in March to stop shipping the tests to provinces.
"Public Health continues to recommend New Brunswickers practise basic healthy behaviours, such as staying home when sick, covering your nose and mouth when coughing and sneezing, washing your hands regularly, and wearing a well-fitted mask in crowded places," reads the release.
"As well, good ventilation can help protect people from respiratory infections."
Anyone with concerns about COVID-19 symptoms should call their health-care provider, Tele-Care 811 or use eVisitNB online health-care services(opens in a new tab).
Free rapid tests will remain available at distribution sites around the province until supplies last.
People may book a pickup appointment through the online scheduler(opens in a new tab). Additional rapid tests will be available for purchase online or at community pharmacies.
The government release adds tests remaining in the government's inventory will expire in September.
Anyone with rapid tests at home is advised to monitor the expiry date on the packing and discard them with regular household waste once expired.
 
@Sharma Ji

Looks like it's a dangerous vaccine.

www.thehindu.com

Covaxin study: Adverse events found in participants

Adolescents and those with comorbidities face higher risks of adverse events post-Covaxin vaccination, as per recent study.
www.thehindu.com www.thehindu.com

Adolescent girls at risk after receiving Covaxin, says study​

Nearly a third of the participants of an observational study on Bharat Biotech’s vaccine reported adverse events of special interest, and serious adverse events may occur in 1% of recipients, a recently published report said​

Updated - May 17, 2024 02:29 am IST
Published - May 16, 2024 06:40 pm IST - NEW DELHI
Bindu Shajan Perappadan
BINDU SHAJAN PERAPPADAN

READ LATER
PRINT
According to the study, which had 1,024 individuals enrolled, 635 adolescents and 291 adults could be contacted during the one-year follow-up. Viral upper respiratory tract infections were reported by 304 (47.9%) adolescents and 124 (42.6%) adults, the study said. Image for representation purposes only. File

According to the study, which had 1,024 individuals enrolled, 635 adolescents and 291 adults could be contacted during the one-year follow-up. Viral upper respiratory tract infections were reported by 304 (47.9%) adolescents and 124 (42.6%) adults, the study said. Image for representation purposes only. File | Photo Credit: Shiv Kumar Pushpakar
Adolescent girls and those with comorbidities are at a higher risk of adverse events after receiving Bharat Biotech’s BBV152 (Covaxin) vaccine against COVID-19, according to a report published in Springer Nature recently. The report said that nearly a third of the participants of an observational study on the vaccine reported adverse events of special interest (AESI).

The one-year follow-up study titled ‘Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: Findings from a one-year prospective study in North India’, conducted by a team of researchers at Banaras Hindu University, also said that serious adverse events many occur in 1% of BBV152 recipients, and that extended surveillance is warranted following the administration of the vaccine.

Doctors group raises concerns over Covishield vaccine side effects
IMG_COVID-19_vaccination_2_1_TGCOB1AN.jpg

Responding to a query from The Hindu on the study, Bharat Biotech maintained that for such a study in safety to be effective and informative, and for it to avoid investigator bias, some data points were also required, including the AESI safety profile of the subjects prior to their participation in the study; a comparison of the safety profile of non-vaccinated subjects during the course of the study; a comparison of the safety profile of subjects who received other vaccines during the course of the study; and that all study participants should be followed during the course of the study instead of only a subset.





“Additionally, several studies have been executed on the safety of Covaxin, and published in peer reviewed journals, demonstrating an excellent safety track record,’’ the company said.
According to the study, which had 1,024 individuals enrolled, 635 adolescents and 291 adults could be contacted during the one-year follow-up. Viral upper respiratory tract infections were reported by 304 (47.9%) adolescents and 124 (42.6%) adults, the study said.
Also Read | ‘We need to stop the fear mongering on vaccines’

Also, new onset skin and subcutaneous disorders (10.5%), general disorders (10.2%), and nervous system disorders (4.7%) were the common AESIs in adolescents. General disorders (8.9%), musculoskeletal disorders (5.8%), and nervous system disorders (5.5%) were the common AESIs in adults. Menstrual abnormalities were noticed in 4.6% of female participants. Ocular abnormalities and hypothyroidism were observed in 2.7% and 0.6% of the participants, respectively.
Among the serious AESIs (1%), stroke and Guillain-Barre syndrome were identified in 0.3% and 0.1% of the participants, respectively.
“Among adolescents, female individuals, those with a history of allergy and post-vaccination typhoid were respectively at 1.6, 2.8, and 2.8 times higher risk of AESIs. The majority of the AESIs persisted at the 1-year follow-up. Female individuals, adolescents with pre-vaccination COVID-19, those with comorbidities, and those with post-vaccination typhoid had respectively 1.6, 2, 2.7, and 3.2 times higher odds of persistent AESIs. Adults with comorbidities had more than 2 times higher odds of AESIs and persistent AESIs,” the paper said.

AstraZeneca’s submission in U.K. court nothing new, say doctors over Covishield’s potential to cause blood clots
covishield%C2%A0vaccine%2005.jpg

The worldwide COVID-19 vaccination programme started in December 2020 and early January 2021. Viral vector and mRNA-based COVID-19 vaccines were distributed on a large scale, worldwide.
In India, the BBV152 was the only vaccine that was initially granted permission for mass roll-out in adolescents in the 15-18 years age group. The short-term safety of COVID-19 vaccines approved for adolescents was shown to be favourable in controlled settings.
“In this context, we provided the first short-term safety data of BBV152 in adolescents and the comparative safety profile in adults. Despite nearly 2 years having elapsed since the approval of COVID-19 vaccines in adolescents, long-term data on the safety of these vaccines released in the public domain have been minimal. Here, in an extension of our previously published study, we provide data on the long-term safety of the BBV152 vaccine in adolescents and adults,” the paper said.
 
https://www.reddit.com/r/CoronavirusDownunder/comments/1ctviaa

Weekly case numbers from around Australia: 9,214 new cases (🔺26%)​

Australia: Case Update

  • NSW 3,470 new cases (🔺33%)
  • VIC 1,580 new cases (🔺14%)
  • QLD 1,448 new cases (🔺21%)
  • WA 600 new cases (🔺22%)
  • SA 1,821 new cases (🔺30%)
  • TAS 89 new cases (🔻14%)
  • ACT 119 new cases (🔺63%)
  • NT 87 new cases (🔺28%)
Notes:
  • Case data is from NNDSS Dashboard that is automated from CovidLive
  • These case numbers are only an indicator for the current trends as most cases are unreported.
  • Multiply by 25 or 30 to get a better indication of actual community case numbers.
  • Only SA still collect or report RAT results.
FluTracker has reported respiratory illnesses activity of 1.8% this week (🔺0.1%), or nearly 1 in 50 people with symptoms. We are slightly below the average for this time of year.
r/CoronavirusDownunder - Weekly case numbers from around Australia: 9,214 new cases (🔺26%)
  • WA 3% (🔺1.7%)
  • TAS 2% (🔺0.8%)
  • NSW 1.8% (🔺0.2%)
  • VIC 1.7% (🔻0.4%)
  • QLD 1.6% (🔺0.2%)
  • SA 1.5% (🔻0.2%)
  • ACT 1.4% (NC)
NSW Respiratory Viruses
While cases are increasing, covid made up just 19% (2,820 cases) of the 15,192 viral infections seen by NSW Health, similar to the levels of RSV (17%) and Influenza (13%). You would have been twice as likely to have the good old common cold (38% Rhinovirus) than covid if you were tested.
  • Rhinovirus 5,844
  • COVID-19 2,820
  • Respiratory syncytial virus (RSV) 2,510
  • Influenza 2,016
  • Parainfluenza 748
  • Adenovirus 723
  • Human metapneumovirus (HMPV) 274
  • Enterovirus 257
This probably excludes RAT results, but it does show that we have the full array of respiratory viruses back in play rather than having covid making up most of the cases.
QLD Hospitalisations
r/CoronavirusDownunder - Weekly case numbers from around Australia: 9,214 new cases (🔺26%)
QLD is seeing a rise of hospitalisations that inline with the increase in cases, quickly heading towards our summer numbers, although these are well below the levels seen back in 2022.
  • Under 18: 4 hospitalisations (2%)
  • 18-64: 41 hospitalisations (20%)
  • 65 to 74: 48 hospitalisations (23%)
  • 75 plus: 113 hospitalisations (55%)
In kids, RSV is the virus making up the majority of cases, with 24 hospitalisations (0-4 year olds) compared to 4 covid and 3 flu hospitalisations in 0-17 year olds.
Most covid hospitalisations are in older adults (65 plus) with 78% of hospitalisations, compared with 54% and 46% for Influenza and RSV hospitalisations respectively and underlines the importance of vaccinations in these age groups that still likely lack the immune maturity to this novel virus.
VIC Hospitalisations
VIC appear to have started weekly COVID-19 surveillance reports again. Snapshot of hospitalisations:
r/CoronavirusDownunder - Weekly case numbers from around Australia: 9,214 new cases (🔺26%)
WA Cases
And finally, there was a big jump in FluTracker numbers from WA this week (3%🔺1.7%), and the latest Surveillance Report (fortnight to 12 May) is reporting large increases in covid cases.
  • COVID-19 notifications increased by 83%, from 597 last fortnight to 1,095 this fortnight.
  • Currently hospitalised cases increased by 57% from an average of 98 per day last fortnight to 154 per day this fortnight.
r/CoronavirusDownunder - Weekly case numbers from around Australia: 9,214 new cases (🔺26%)
 

H5N1 news, CDC wastewater surveillance for bird flu, FLiRT variants, and the latest COVID symptoms​


 

COVID lawsuit: Utah mom says AstraZeneca vaccine disabled her | Cuomo​


 

Oregon health officials monitor new COVID-19 variant​


 

Dan Andrews' 'unreasonable iron hand' responsible for 'violent' response to COVID protests​


 

Log in to Facebook

Log in to Facebook to start sharing and connecting with your friends, family and people you know.
www.facebook.com www.facebook.com

Janet Hanlin​

Admin
DATLXNb2OiK.png
Top contributor
· opsnStdoerfama010gi15544a35lhuf653821mm167umi3h1t7tgca5t7fhc ·

Weekly Ontario Update for Friday, May 10, 2024:​

Public Health Ontario has further reduced the amount of data available to the public. In addition, Health Canada has stopped reporting hospitalization data as some provinces are no longer tracking COVID hospitalizations. Unless indicated otherwise, information in this update includes data from Sunday, April 28 to Saturday, May 4, so data is delayed.

Data relating to deaths is even further delayed as cause of death is taking MONTHS to be determined. So recent deaths are far WORSE that are being reported.
  • Recent cases: 884 (+ 132 compared to last week)
    🙁

    Estimates suggest that the actual number of new cases could be more than 10 times higher than what is being reported due to limited eligibility for testing!
  • Weekly positivity rate: 7.3% (+ 1.0% since last week)
    🙁
  • Recent deaths: 2 (6 fewer than last week)
    Recent deaths are a lagging indicator of the current level of new cases. Deaths are underreported because they are based on date of death and by the time the cause of death is reported, it is no longer considered recent!
  • Average daily hospital bed occupancy: 334* (+ 76 since last week week)
    🙁

    *Please interpret the COVID-19 hospitalization data with caution as not all centers are reporting.    .
Full list of those eligible for testing can be found here (updated): https://www.ontario.ca/.../covid-19-testing-and-treatment...
Sources: Total cases, total deaths, testing levels and wastewater levels: https://www.publichealthontario.ca/.../Respiratory-Virus...
Some additional COVID stats and info: https://twitter.com/MoriartyLab
 
You must log in or register to reply here.

Users who are viewing this thread

Total: 1 (members: 0, guests: 1)

Pakistan Defence Latest

Country Watch Latest

Latest Posts

Share this page

Back
Top